The filing was based on results from the phase 3 THALES trial, which showed aspirin plus Brilinta 90 mg used twice daily ... form for those unable to take tablets, and for long-term use in ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor Tablets for heart attack and stroke prevention, ...